欧盟 -
冰岛文 -
EMA (European Medicines Agency)
tabrecta
novartis europharm limited - capmatinib dihydrochloride monohydrate - krabbamein, lungnakrabbamein - Æxlishemjandi lyf - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.
冰岛 -
冰岛文 -
LYFJASTOFNUN (Icelandic Medicines Agency)
brieka hart hylki 150 mg
teva b.v.* - pregabalinum inn - hart hylki - 150 mg
冰岛 -
冰岛文 -
LYFJASTOFNUN (Icelandic Medicines Agency)
brieka hart hylki 75 mg
teva b.v.* - pregabalinum inn - hart hylki - 75 mg
冰岛 -
冰岛文 -
LYFJASTOFNUN (Icelandic Medicines Agency)
brieka hart hylki 300 mg
teva b.v.* - pregabalinum inn - hart hylki - 300 mg
冰岛 -
冰岛文 -
LYFJASTOFNUN (Icelandic Medicines Agency)
brieka hart hylki 25 mg
teva b.v.* - pregabalinum inn - hart hylki - 25 mg
冰岛 -
冰岛文 -
LYFJASTOFNUN (Icelandic Medicines Agency)
duac hlaup
stiefel laboratories legacy (ireland) ltd - benzoylis peroxidum; clindamycinum fosfat - hlaup
冰岛 -
冰岛文 -
LYFJASTOFNUN (Icelandic Medicines Agency)
folsyra evolan tafla 5 mg
evolan pharma ab - folic acid - tafla - 5 mg
冰岛 -
冰岛文 -
LYFJASTOFNUN (Icelandic Medicines Agency)
isotretinoin alvogen (isotretinoin ratiopharm) mjúkt hylki 20 mg
alvogen ehf. - isotretinoinum inn - mjúkt hylki - 20 mg
冰岛 -
冰岛文 -
LYFJASTOFNUN (Icelandic Medicines Agency)
venlafaxine bluefish hart forðahylki 150 mg
bluefish pharmaceuticals ab - venlafaxinum hýdróklóríð - hart forðahylki - 150 mg
冰岛 -
冰岛文 -
LYFJASTOFNUN (Icelandic Medicines Agency)
xeomin stungulyfsstofn, lausn 100 ein.
merz pharmaceuticals gmbh - botulinum toxin type a - stungulyfsstofn, lausn - 100 ein.